| API | Isem tal-Prodott | KAŻ NRU. | Klassifikazzjoni |
| Canagliflozin | 2-(4-Fluorophenyl)-5-[(5-jodo-2-methylphenyl)methyl]thiophene | 898566-17-1 | dijabete |
| Empagliflozin | (3S)-3-[4-[(5-Bromo-2-chlorophenyl)metil]fenossi]tetraidro-furan | 915095-89-5 | dijabete |
| Linagliptin | 8-bromo-7-(but-2-inil)-3-metil-1H-purine-2,6(3H,7H)-dione | 666816-98-4 | dijabete |
| Linagliptin | 2-(chloromethyl)-4-methylquinazoline | 109113-72-6 | dijabete |
| Linagliptin | 8-Bromo-7-but-2-inil-3-metil-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione | 853029-57-9 | dijabete |
| Saxagliptin | (1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester | 361440-67-7 | dijabete |
| Saxagliptin | (alphaS)-alpha-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-hydroxytricyclo[3.3.1.13,7]decane-1-acetic acid | 361442-00-4 | dijabete |
| Sitagliptin | Aċidu 2,4,5-Trifluorofenilaċetiku | 209995-38-0 | dijabete |
| Sitagliptin | Boc-(R)-3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Butyric Acid | 486460-00-8 | dijabete |
| Sitagliptin | 3-(Trifluworomethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride | 762240-92-6 | dijabete |
| Vildagliptin | L-Prolinamide | 7531-52-4 | dijabete |
| Vildagliptin | (2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile | 207557-35-5 | dijabete |
| Empagliflozin Dapagliflozin/Canagliflozin | 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone | 32384-65-9 | dijabete |
| Vildagliptin | L-Prolinamide | 7531-52-4 | dijabete |
| Liraglutide | Liraglutide | 204656-20-2 | dijabete |
| ABT-888 | (S)-2-Methylproline | 42856-71-3 | Kontra l-kanċer |
| Docetaxel | 10-Deacetylbaccatin III | 32981-86-5 | Kontra l-kanċer |
| Lenvatinib | 4-chloro-7-methoxyquinoline-6-carboxamide | 417721-36-9 | Kontra l-kanċer |
| Lenvatinib | 4-Amino-3-chlorophenol hydrochloride | 52671-64-4 | Kontra l-kanċer |
| Acalabrutinib | (3-Chloropyrazin-2-yl) MethanaMine hydrochloride | 939412-86-9 | Kontra l-kanċer |
| Acalabrutinib | N-Benzyloxycarbonyl-L-proline | 1148-11-4 | Kontra l-kanċer |
| Acalabrutinib | N-Pyridin-2-yl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide | 1383385-64-5 | Kontra l-kanċer |
| Acalabrutinib | Aċidu 2-Butynoic | 590-93-2 | Kontra l-kanċer |
| Nilotinib | 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluorometil)anilina | 641571-11-1 | Kontra l-kanċer |
| Nilotinib | Diphenylphosphoryl azide | 26386-88-9 | Kontra l-kanċer |
| Nilotinib | aċidu 4-Metil-3-[[4-(3-piridinil)-2-pirimidinil]amino]benżojku | 641569-94-0 | Kontra l-kanċer |
| Nilotinib | 1-(3-Pyridyl)-3-(dimethylamino)-2-propen-1-one | 55314-16-4 | Kontra l-kanċer |
| Abiraterone Aċetat | 17-Iodoandrosta-5,16-dien-3beta-ol | 32138-69-5 | Kontra l-kanċer |
| Abiraterone Aċetat | 17-Iodoandrosta-5,16-dien-3beta-ol 3-aċetat | 114611-53-9 | Kontra l-kanċer |
| Neratinib | 3-chloro-4-(piridin-2-ylmethoxy)anilina | 524955-09-7 | Kontra l-kanċer |
| Neratinib | N-(4-Chloro-3-cyano-7-ethoxy-6-quinolinyl)acetamide | 848133-76-6 | Kontra l-kanċer |
| Neratinib | 6-amino-4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-7-ethoxyquinoline-3-carbonitrile | 848139-78-6 | Kontra l-kanċer |
| Neratinib | trans-4-Dimethylaminocrotonic acid hydrochloride | 848133-35-7 | Kontra l-kanċer |
| Palbociclib | tert-butil 4-(6-amino-3-pyridyl)piperazine-1-carboxylate | 571188-59-5 | Kontra l-kanċer |
| Palbociclib | 6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one | 1016636-76-2 | Kontra l-kanċer |
| Ribociclib | 2-Chloro-7-cyclopentyl-n,n-dimethyl-7h-pyrrolo[2,3d]pyrimidine-6-carboxamide | 1211443-61-6 | Kontra l-kanċer |
| Ribociclib | aċidu 2-Kloro-7-ċiklopentil-7H-pirrolo[2,3-d]pirimidin-6-karbossiliku | 1211443-58-1 | Kontra l-kanċer |
| Ceritinib/Crizotinib | 4-(4-Bromopyrazol-1-yl)piperidine-1-carboxylic acid tert-butyl ester | 877399-50-3 | Kontra l-kanċer |
| Ceritinib/Crizotinib | tert-Butil 4-[4-(4,4,5,5-tetrametil-1,3,2-dioxaborolan-2-il)-1H-pirazol-1-il]piperidin-1-karbossilat | 877399-74-1 | Kontra l-kanċer |
| Ceritinib/Crizotinib | (S)-1-(2,6-Dichloro-3-fluorophenyl)etanol | 877397-65-4;42247-74-5 | Kontra l-kanċer |
